CYMODIQ Trademark

Trademark Overview


On Thursday, March 23, 2023, a trademark application was filed for CYMODIQ with the United States Patent and Trademark Office. The USPTO has given the CYMODIQ trademark a serial number of 97853485. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, July 26, 2024. This trademark is owned by Pfizer Inc.. The CYMODIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
cymodiq

General Information


Serial Number97853485
Word MarkCYMODIQ
Filing DateThursday, March 23, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, July 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Monday, March 27, 2023NEW APPLICATION ENTERED
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 11, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024SOU EXTENSION 1 FILED
Friday, July 26, 2024SOU EXTENSION 1 GRANTED